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Abstract 
In the present study, we examined the effect of the over-expression of LMNA, or its mutant form progerin (PG), on 
the mesoderm differentiation potential of mesenchymal stem cells (MSCs) from human umbilical cord (UC) stroma 
using a recently described differentiation model employing spheroid formation. 
Accumulation of lamin A (LMNA) was previously associated with the osteoarthritis (OA) chondrocyte phenotype. 
Mutations of this protein are linked to laminopathies and specifically to Hutchinson–Gilford Progeria Syndrome 
(HGPS), an accelerated aging disease. Some authors have proposed that a deregulation of LMNA affects the 
differentiation potential of stem cells. 
The chondrogenic potential is defective in PG-MSCs, although both PG and LMNA transduced MSCs, have an 
increase in hypertrophy markers during chondrogenic differentiation. Furthermore, both PG and LMNA-MSCs 
showed a decrease in manganese superoxide dismutase (MnSODM), an increase of mitochondrial MnSODM-
dependent reactive oxygen species (ROS) and alterations in their migration capacity. Finally, defects in 
chondrogenesis are partially reversed by periodic incubation with ROS-scavenger agent that mimics MnSODM 
effect. 
Our results indicate that over-expression of LMNA or PG by lentiviral gene delivery leads to defects in chondrogenic 
differentiation potential partially due to an imbalance in oxidative stress. 
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Introduction 
MSCs are multipotent cells having the capacity to differentiate into various cell lineages, some of which 
generate bone, cartilage and adipose tissue (Arufe et al., 2011). Cells expressing MSC markers have been 
found in many tissues including the synovial membrane and cartilage tissues (Hermida-Gómez et al., 
2011). In addition, osteoarthritic synovial membrane and cartilage contain more cells expressing MSC 
markers than do synovial membranes from healthy joints (Nagase et al., 2008). MSCs are likely to be 
agents of connective tissue homeostasis and repair. 
Lamin A and lamin C (A-type lamins, both encoded by the LMNA gene) are major components of the 
mammalian nuclear lamina, a complex pertinacious structure that acts as a scaffold for protein complexes 
that regulate nuclear structure and function (Gruenbaum et al., 2003 and Prokocimer et al., 2009). 
Mutations in the LMNA gene play a key role in the pathogenesis of a group of diseases called 
laminopathies, affecting mesoderm tissues (Worman et al., 2010). One of the most studied laminopathies 
is Hutchinson–Gilford Progeria Syndrome (HGPS) which is due, in most of the cases, to nuclear 
accumulation of a permanently farnesylated, mutant form of prelamin A called progerin (PG) (Eriksson et 
al., 2003). HGPS is a very rare and fatal genetic disorder characterized by cellular senescence and an 
early onset of pathologies typical of advanced age such as atherosclerosis, myocardial infarction, stroke 
or OA (Hennekam, 2006). Remarkably, PG is also present in normal cells and appears to progressively 
accumulate during aging of non-HGPS cells (Wang et al., 2008). Besides producing structural defects in 
the nuclear lamina, it has also been suggested that PG may interfere with the proposed gene regulatory 
function of lamins, specifically the regulation of the p16/Rb pathway necessary to maintain balance 
between differentiation and proliferation of multipotent mesenchymal stromal or stem cells (MSCs) in 
tissue regeneration (Espada et al., 2008, Scaffidi and Misteli, 2008 and Hernandez et al., 2010). 
Recently, increased accumulation of lamin A in osteoarthritis (OA) chondrocytes and cartilage (Ruiz-
Romero et al., 2008 and Attur et al., 2012) has been reported. OA is one of the most common skeletal 
disorders clinically manifested by joint pain, swelling and progressive loss of function. It is characterized 
by cartilage degradation, hypertrophy of the subchondral bone and osteophyte formation at the joint 
margins (Lamas et al., 2010). Although the underlying molecular mechanisms involved in the disease 
remain unknown, the etiology of OA has been considered an articular cartilage disorder induced by 
mechanical stress, articular injuries, involvement of inflammatory mediators and aging. Evidence 
suggests that cellular senescence of the chondrocyte is inherent to the OA process (Loeser, 2011). Finally, 
progression of the disease has been shown to be therapeutically modulated by MSCs (Mafi et al., 
2011 and van Buul et al., 2012). 
The aim of this study was to demonstrate whether lamin A deregulation in MSCs modulates the 
chondrogenesis process. We demonstrated that over-expression of lamin A and PG reduces the 
chondrogenic capacity of MSC. We also provided evidence that linked those defects to alterations in 
oxidative stress response through using N-acetylcysteine which protects against hypoxia produced by 
production of oxygen reactive species (Cillero-Pastor et al., 2008). 
Material and methods 
Tissue collection 
Human UCs were obtained from cesarean sections performed on healthy women at the Maternity Facility 
of Complejo Hospitalario Universitario A Coruña (CHUAC). All tissues were obtained with fully 
informed consent and ethical approval by the supervisor of the Ethical Committee (CEIC) of Galicia. The 
UC donors were between 26 and 35 years-old. 
Isolation and culture of MSCs 
MSCs were isolated from UC stromal tissue using a previously described protocol (Arufe, de la Fuente et 
al., 2011). Briefly, the tissue was washed with phosphate-buffered saline (PBS) and cut in small pieces, 
termed “explants;” which were incubated for three five-minute periods in an enzymatic cocktail 
containing 1.2 U/mL dispase and 112 U/mL collagenase type I (Sigma-Aldrich, St. Louis, Missouri, 
USA). The explants were cultured in Dulbecco's Modified Eagles Medium (DMEM) with 10% fetal 
bovine serum (FBS), 1% penicillin and 1% streptomycin (Sigma-Aldrich) until adhered to the plastic 
plate. After three days, the explants were removed, leaving the attached UC MSCs, which continued 
monolayer culture in the same medium. When the cells were 90% confluent, they were removed from the 
plate using 2% trypsin (Sigma-Aldrich) in PBS and induced to differentiate toward mesoderm cell lines. 
The cells were characterized by flow cytometry using a FACSAria flow cytometer (BD Bioscience, 
Madrid, SP) to check the following surface markers: PE-conjugated anti-human CD73 (1:20 from BD 
Pharmingen); PE-Cy5.5-conjugated mouse anti-human CD90 (1:20 from BD Pharmingen); FITC mouse 
anti-human CD105: (1:100 from Serotec, Bavaria, Germany); FITC mouse anti-rat CD45 (1:20 BD 
Pharmingen) and CD34 (1:20 from DakoCytomation, Barcelona, SP). FACS data were generated by 
DIVA software (BD Bioscience). Negative control staining was performed using FITC-conjugated mouse 
IgG1k isotype, PE-conjugated mouse IgG1k isotype and PE-Cy5.5-conjugated mouse IgG1k isotype (all 
from BD Pharmingen). Cells were fixed in 4% paraformaldehyde in PBS. After fixation, the cells were 
washed twice with PBS, permeabilized with PBS containing 0.1% Triton X-100 (Sigma-Aldrich) for 
10 min, then pre-blocked with 3% bovine serum albumin (BSA) and incubated with the different 
antibodies tested for 30 min at room temperature. The stained cells were then washed twice with PBS and 
1 × 105 cells were analyzed.  
Cloning procedure 
Full length human PG, LMNA and green fluorescent protein (GFP) cDNAs were amplified by 
polymerase chain reaction (PCR) from pBABE-puroGFP-progerin and pBABE-puroGFP-lamin A 
plasmids (Addgene, donated by Tom Misteli), using the oligonucleotides EcoRI-LMNA-forward: 
CCGGAATTCATGGAGACCCCGTCCCAGCGG, BamHI-LMNA-reverse: 
CGCGGATCCTTACATGATGCTGCAGTTCTG, EcoRI-GFP-forward: 
CCGGAATTCATGGTGAGCAAGGGCGAG, BamHI-GFP-reverse: 
CGCGGATCCTTACTTGTACACCTCGTC. GFP, LMNA and PG were cloned into pLVX-puro 
(Clontech Laboratories Inc., Mountain View, CA) in between the EcoRI/BamHI sites following standard 
cloning procedures. 
Lentiviral production 
The Lenti-X™ Lentiviral Expression System (Clontech Laboratories Inc.) was used following the 
manufacturer's protocol. One day before transfection 4 × 106 293T producer cells were placed on 100 mm 
plates in penicillin/streptomycin-free DMEM supplemented with 5% FBS. The following day, three 
different calcium-phosphate based transfections were performed using LVX-GFP-puro, LVX-Progerin-
puro and LVX-lamin A-puro. The cells were incubated overnight with the transfection mixture, then 
washed with PBS and incubated with 8 mL of fresh complete growth medium. 
Viral supernatants were collected at 48 h, 60 h and 72 h following transfection, centrifuged, filtered to 
remove cell debris and stored at 4 °C until transduction. 
Transduction of human UC MSCs 
Target cells were plated in 100 mm plates at 6 × 106 cells per plate. After one day, the cells were 70% 
confluent. The cells were incubated sequentially with the 48 hour, 60 hour, and 72 hour viral supernatants 
for 12 h. Following the last transduction, the cells were washed and incubated with fresh growth medium 
to allow puromycin-resistance expression. Two days later, puromycin selection was performed by 
incubating the cells in growth media supplemented with 1 μg/mL puromycin (Clontech Laboratories Inc.) 
for five days. After selection, transduced cells were washed and allowed to recover in complete media for 
two days. 
Proliferation assay 
Different numbers of cells (0, 1000, 2000, 4000, 8000 and 16,000), plated in triplicate in 96-well plates 
and allowed to adhere for 8 h, were used to calculate the proliferation curve. The number of cells was 
then calculated using CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega, 
Madison, WI, USA) following manufacturer's instructions. For the assay, 4000 cells were plated for each 
cell line in triplicate in 96-well plates, and the total number of cells was calculated at different time points 
(0, 2, 4 and 6 days). 
Chondrogenic differentiation 
MSCs transduced with GFP, LMNA or PG were seeded into 96-well plates (Sarstedt, Inc., Barcelona, SP) 
at 2 × 104 cells per well in DMEM with 10% FBS, 1% penicillin, 1% streptomycin, 1.5 × 10− 4 M 
monothioglycerol (MTG), 5 mg/mL ascorbic acid (AA), and 6 μg/mL transferrin (TRANS) (all from 
Sigma-Aldrich) to facilitate spontaneous spheroid formation. The medium was then changed after two 
days to chondrogenic medium composed of DMEM with 15% knockout serum (Gibco, Invitrogen, 
Barcelona, SP), 5 mg/mL AA, 6 μg/mL TRANS, 10 μM dexamethasone (DEX), 1 × 10− 7 M retinoic acid 
and 1 ng/mL recombinant human transforming growth factor-β3 (rhTGF-β3) (ProSpec-Tany 
TechnoGene, Deltaclon, Madrid, SP). This medium was changed every three days. After 21 days in the 
chondrogenic medium, the spheroids formed were collected, frozen and stored at − 80 °C for later 
analyses. For the N-acetyl-cysteine (NAC) pulses, spheroids were incubated with DMEM, 10% knockout 
serum (Gibco, Invitrogen), 1% penicillin and 1% streptomycin (Sigma-Aldrich) with 20 μg NAC for 1 h 
daily for three days prior to regular change of the differentiation media. Control spheroids were incubated 
under the same conditions in DMEM with 10% knockout serum, 1% penicillin, and 1% streptomycin 
without NAC.  
Adipogenic and osteogenic differentiation 
MSCs transfected with LMNA, PG or GFP were seeded into 96-well plates (Sarstedt Inc.) at 2 × 104 cells 
per well in adipogenic or osteogenic commercial medium (Cambrex, Lonza, A Coruña, SP), following the 
manufacturer's instructions, to assess the mesoderm differentiation potential. Adipogenic cultures were 
stained with Oil Red O after 21 days of culture. For staining, the culture plates were fixed in 10 mM 
sodium periodate, 2% paraformaldehyde, 75 mM l-lysine dihydrochloride, and 37.5 mM dibasic sodium 
phosphate (Sigma-Aldrich) at pH 7.4 for 15 min at room temperature, then air dried and treated with a 
filtered solution of 0.3% Oil Red O to stain lipid droplets. After 21 days in culture, the osteogenic cultures 
were stained with alizarin red S to assess calcium deposits. Following fixation, the cells were covered 
with alizarin red S 2% aqueous solution at pH 4.2 (Sigma-Aldrich) for 3 min, then washed thoroughly 
with distilled water. 
RNA extraction and cDNA synthesis 
Total RNA was extracted from cultured cells using the Trizol L.S. reagent method (Invitrogen). Reverse 
transcription (RT) used the SuperScript II system (Invitrogen). Total RNA (2 μg) was reverse transcribed 
in a 20 μL reaction volume containing SuperScript II (200 units), random primers (25 μM), and dNTP 
(0.5 mM each) at 42 °C for 50 min. 
Real-time reverse transcriptase PCR (RT-PCR) analysis 
The reported sequences of genes for human SOX2 (forward: gtacccgcacttgcacaac; reverse: 
tcgctctcgttcagaagtctc), Nanog (forward: atgcctcacacggagactgt; reverse: aagtgggttgtttgcctttg), Oct3/4 
(forward: ctcctggagggccaggaatc; reverse: atatacacaggccgatgtgg), SOX9 (forward: ctccgggacatgatcagc; 
reverse: ggtagtgctgggacatgtgaa), lipoprotein lipase (LPL) (forward: agaacatcccattcactctgc; reverse: 
ccatttgagcttcaacatgagt), fatty acid binding protein (FABP) (forward: ggatgataaactggtggtgga; reverse: 
cacagaatgttgtagagttcaatc), adiponectin (ADIPOQ) (forward: ggtgagaaaggagatccaggt; reverse: 
tgctgagcggtatacataggc), alkaline phosphatase (ALP) (forward: gacggacccgtcactctc; reverse: 
gtgcccgtggtcaattct), osteocalcin (OC) (forward: ggcgctacctgtatcaatgg; reverse: tcagccaactcgtcacagtc), 
Runx2 (forward: gtgcctaggcgcatttca; reverse: tgactggcggcgtgcaag), aggrecan (AGG) (forward: 
gcctacgaagcaggctatga; reverse: gcacgccataggtcctga) and RPLP (forward: tctacaaccctgaagtgcttgat; reverse: 
caatctgcagacagacactgg) as housekeeping were used for primer design. SOX9 was used to check the 
expression of genes involved in the early chondrogenic stage. Nanog and Sox2 were used to check the 
expression of genes involved in non-differentiation stages. Genes for human LPL, FABP and ADIPOQ, 
identified with early and late adipogenic differentiation, and ALP, OC and Runx2 with early and late 
osteogenic differentiation, were utilized to determine the success of differentiation. The amplification 
program consisted of an initial denaturation at 92 °C for 2 min followed by 40 cycles from 92 °C for 15 s, 
annealing at 61 °C for 30 s, and an extension at 72 °C for 15 s. Each PCR analysis was done in duplicate, 
with each set of assays repeated three times. To minimize effects of unequal quantities of starting RNA 
and to eliminate potential sources of inconsistency, relative expression levels of each gene were 
normalized to RPLP using the 2-ΔΔCt method (Livak and Schmittgen, 2001). Control experiments 
contained no reverse transcriptase. 
Histological, immunofluorescence and immunohistochemical analysis 
Spheroids engineered from MSCs following their differentiation into chondrocyte-like cells were frozen 
in OCT embedding matrix (BDH Chemicals, Poole, UK). Full-depth sections (4 μm) were cut with a 
cryostat and fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) in PBS at pH 7.6. Some sections were 
stained with safranin O (Sigma-Aldrich) to evaluate the distribution of proteoglycans, others were 
immunostained with monoclonal antibodies against collagen type 1 (COL1; 1:1000), collagen type 2 
(COL2; 1:50) and collagen type 10 (COLX ;1:2000), matrix metalloproteinase-13 (MMP-13; 1:200) and 
aggrecan (AGG ; 1:50) (Southern Biotechnologies, Birmingham, AL USA) and treated as described by 
Arufe et al. (2009). Biotinylated secondary antibodies were detected using a peroxidase-labeled biotin–
streptavidin complex (Vectastain Elite kit; Vector Laboratories, Peterborough, UK) with 
diaminobenzidine substrate (Vector Laboratories) (1:1000). Normal mouse serum was used for the 
negative control, and the sections were not counterstained. 
Control-MSCs and transduced MSCs were grown in 8-chamber slides at a density of 2 × 104 cells per 
chamber. When they reached 80% confluency, cells were fixed with paraformaldehyde 5% in phosphate 
buffered saline and processed as previously described (Arufe et al., 2009) in order to study the nuclear 
morphology by immunofluorescence using mouse lamin A + C (Acris Antibodies) (1:100) as primary 
antibody and PE-anti rabbit (BD Science) (1:1000) as secondary antibody. 
Densitometry analysis 
AnalySIS Image Processing was used to quantify the expression of antibodies obtained by 
immunohistochemical analyses of sections of spheroids. Three 200 mm2 fields were quantified for each 
antibody; immunohistochemistry values were expressed in arbitrary units assigned by computer program. 
The values were expressed as percentage of positive cells for each of the markers studied. 
Immunoblot procedures 
Immunoblot analysis was performed on 20 μg of total protein extracted from cells in culture, as 
previously described (Matsushime et al., 1994). The antibodies used were mouse lamin A + C (Acris 
Antibodies), rabbit β-catenin (Santa Cruz Biotech., Santa Cruz, CA), rabbit notch-2 (Santa Cruz 
Biotech.), rabbit glycerol-3-phosphate dehydrogenase (GPDH) (Amersham), mouse MnSODM (Santa 
Cruz Biotech.), and rabbit AKT (Cell Signaling, Danvers MA). Secondary anti-mouse and anti-rabbit 
antibodies (Amersham) were used to visualize proteins by the ECL™ Western Blotting Analysis System 
(GE Healthcare, Amersham Biotechnology, UK). N = 3. Ideal concentrations for each antibody were 
determined empirically. Working concentrations were 1:1000 of the stock solutions. 
ROS measurement 
The percentage of positive cells after treatment with DCFH-DA-2′7′-dichlorofluorescein diacetate (Fluka) 
was calculated in triplicate as previously described (Cillero-Pastor et al., 2008). Briefly, 500,000 cells 
plated in 6-well plates were allowed to grow to 80% confluence, then incubated sequentially with or 
without NAC for 1 h, washed, and incubated with 10 μM DCFH-DA for 30 min. The cells were then 
recovered in a tube and analyzed using flow cytometry in a FACSAria instrument (Benton Dickinson). 
The percentage of positive cells was measured for each condition by fluorescent emission at 488 nm; 
basal levels calculated from the control without fluorophore were subtracted for each measurement. 
Oriented cell migration assay 
Cells were detached from regular Petri dishes after reaching a confluence of 80% and 50,000 cells of each 
cell line were seeded in triplicate on the upper compartment of a modified Boyden's chamber (Corning, 
Cultek SLU, Madrid, SP) in 200 μL of serum-free medium. The chambers were then introduced in 24-
well plates with either serum-free medium or serum-free medium supplemented with 10 ng/mL of stromal 
cell-derived factor-1 (SDF-1) or 50 pg/mL of interleukin-8 (IL-8) as chemotactic agents. After 24 hour 
incubation in normoxic conditions, cell migration through the filter were evaluated by trypan-blue cell 
staining and cell counting in 18 randomly selected microscopy fields. 
Statistics 
All experiments were done in triplicate and representative results are shown. Statistical analyses used 
were Student's t test and analysis of variance (ANOVA) using SPSS 16.0 (source). P < 0.05 was 
considered statistically significant — P < 0.1 for the chondrogenic differentiation with NAC.  
Results 
LMNA and PG accumulation in LMNA-MSCs and PG-MSCs 
The expression of lamin isoforms in GFP-MSCs was similar to their expression in non-transduced MSCs. 
PG over-expression in PG-MSCs produced alterations in the nuclear membrane (blebs and LMNA 
accumulation), typical from PG-expressing cell lines (Fig. 1A). The efficiency of gene delivery and 
protein expression was determined using immunoblot analysis of the transduced cells with anti-lamin 
A + C antibody. Ag1972 HGPS cell line was included as a positive control. LMNA-MSCs showed 
accumulation of wild type (wt) LMNA and its precursor pre-lamin A (PLMNA) (Fig. 1B). PG-MSCs 
expressed the lower molecular weight isoform progerin (PG). Mild nuclear defects are only eventually 
detected in LMNA-MSCs. Furthermore, LMNA and PG over-expressing MSCs show a decrease in their 
proliferation rate (Fig. 1C). 
 
 
 
Figure 1. Characterization of mesenchymal stem cells (MSCs) transduced with progerin (PG), lamin A (LMNA) or green 
fluorescent protein (GFP). Representative image of the immunofluorescence analysis of the nuclear distribution of LMNA using anti 
LMNA antibody (A). Representative image of Western-blot analysis using LMN A + C antibody from three experiments. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the housekeeping gene (B). Proliferation rate of the different 
cell lines (C). PLMNA = pre-LMNA; MSC = mesenchymal stem cells not transduced; Ag1972 = HGPS cell line. 
  
GFP-MSCs differentiation potential comparing to that of non-transduced MSCs 
To use the GFP-transduced cells as controls for the differentiation study, we first characterized this cell 
line. The expression of stem cell genes, including Nanog, Oct4 and Sox9, was not significantly different 
when GFP-MSCs were compared to non-transduced MSCs as determined by real-time RT-PCR 
(Supplementary Fig. 1A). Primary chondrocytes used as a control did present a significantly (P < 0.05) 
higher expression of Sox9, an early chondrogenesis gene, compared to GFP-MSCs and non-transduced 
MSCs (Supplementary Fig. 1A). The directed differentiation of GFP-MSCs and non-transduced MSCs 
toward adipogenesis (Supplementary Figs. 1D–F), osteogenesis (Supplementary Figs. 1G–I) and 
chondrogenesis (Supplementary Figs. 1J–L), did not produce any significant differences between the two 
cell types when examined by immunohistochemistry and RT-PCR analyses. 
Differential potential of PG-MSCs and LMNA-MSCs vs GFP-MSCs 
After 21 days in osteogenic medium, almost 100% of the GFP- and LMNA-transduced cells were positive 
for alizarin red stain, compared with 40% of the PG-MSCs (Figs. 2A–B, Supplementary Fig. 2). Genetic 
studies revealed that LMNA-MSCs expressed the highest level of the OC gene, while PG-MSCs showed 
the significant (P < 0.05) lowest ALP expression (Fig. 2B). 
 
 
 
Figure 2. Osteogenic and adipogenic potential of mesenchymal stem cells (MSCs) transduced with progerin (PG), lamin A 
(LMNA) or green fluorescent protein (GFP). Cultures were stained with alizarin red S to assess calcium deposits; densitometry 
analysis of calcium deposit staining (A). Real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of the 
osteogenic differentiation genes ALP and OC for the three cell lines (B). Oil Red O staining of lipid vesicles; densitometry analysis 
of the Oil-Red staining (C). Real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of the adipogenic 
differentiation genes LPL and FABP for the three cell lines (D). *P < 0.05 is considered significant using Student's t test versus 
GFP-MSCs. 
Almost 45% of the seeded GFP-MSCs and LMNA-MSCs were positive for Oil Red O stain, showing 
adipogenesis, compared with 25% of the PG-MSCs (Figs. 2C–D, Supplementary Fig. 2). The expression 
of the LPL and FABP genes was significantly (P < 0.05) higher in LMNA-MSCs than in the GFP-MSCs 
controls, by as much as 100-fold. In contrast, the expression of these genes was lower in PG-MSCs than 
in GFP-MSCs (Fig. 2D). 
PG-MSCs present a chondrogenic characteristic ratio of COL2 to COL1 significantly much lower 
than LMNA-MSCs and GFP-MSCs, as revealed by immunohistochemistry (Fig. 3A) and RT-PCR 
(Fig. 3B). The histomorphologic study of chondrogenesis demonstrated that PG-MSCs had decreased 
staining for COL2 and safranin O (proteoglycans) compared to LMNA-MSCs and GFP-MSCs (Fig. 3C 
and Supplementary Fig. 2). These results were corroborated by real-time RT-PCR analysis of COL2 and 
AGG gene expression (Fig. 3D). Hypertrophy studies during chondrogenesis used immunohistochemistry 
to demonstrate the role of LMNA and PG in the process of MSC differentiation. Immunohistochemical 
analysis of the hypertrophy marker COLX demonstrates that this protein was significantly increased in 
both PG and LMNA-MSCs (Fig. 3E and Supplementary Fig. 2); this finding was validated by real-time 
RT-PCR (Fig. 3F). The gene expression of MMP-13, another classical hypertrophy marker, was 
significantly higher in LMNA and PG-MSCs (Fig. 3F). In this case, the immunohistochemical analysis 
showed a significant (P < 0.05) increase of MMP-13 only in PG-MSCs when compared to control GFP-
MSCs (Fig. 3E and Supplementary Fig. 2). 
 
 
 
Figure 3. Chondrogenic potential and markers of hypertrophy during chondrogenic differentiation of mesenchymal stem cells 
(MSCs) transduced with progerin (PG), lamin A (LMNA) or green fluorescent protein (GFP). Densitometry of the immunostaining 
for collagen type 2 (COL2) and collagen type 1 (COL1). COL2/COL1 ratio is shown (A). Real-time reverse transcriptase 
polymerase chain reaction (RT-PCR) analysis of the COL2/COL1 ratio (B). Densitometry analysis of COL2 and safranin O staining 
of proteoglycans (C). Real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of the chondrogenic 
differentiation genes COL2 and AGG (D) for the three cell lines. Densitometry analysis of the immunostaining for matrix 
metalloproteinase-13 (MMP13) and collagen type X (COLX) (E). Real-time reverse transcriptase polymerase chain reaction (RT-
PCR) analysis of hypertrophy markers COLX and MMP13 (F). *P < 0.05 was considered significant using Student's t analysis 
versus GFP-MSCs. 
Role of reactive oxygen species 
Western-blot analysis showed that MnSODM expression is diminished in both PG-MSCs and LMNA-
MSCs compared to the control GFP-MSCs (Fig. 4A). The spontaneous production of ROS was 
significantly (P < 0.05) higher in PG-MSCs and LMNA-MSCs than in the control GFP-MSCs (Fig. 4B). 
Treatment of the cells for 1 h with NAC reduced the accumulation of ROS from the baseline levels 
(Fig. 4B).  
 
 
 
Figure 4. Levels of manganese superoxide dismutase (MnSODM), reactive oxygen species ROS production of mesenchymal stem 
cells (MSCs) transduced with progerin (PG), lamin A (LMNA) or green fluorescent protein (GFP) and the effect on oriented 
migration capacity. Western blot analysis of the lamin isoforms and MnSODM in the three cell lines (A). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as the housekeeping gene. Flow cytometry of GFP-MSCs, LMNA-MSCs and PG-
MSCs after one hour incubation with N-acetyl-cysteine (NAC) or treatment with hydrogen peroxide (H2O2) (B). Iso = no treatment; 
NAC20 = 20 μg NAC; NAC40 = 40 μg NAC; H2O2 = 20 μg; DCFH = 10 μM 2′7′-dichlorofluorescein diacetate control. Modified 
Boyden's chamber assay of the three cell lines to test their oriented attraction capacity to SDF-1 and IL-8 (C). *P < 0.05 was 
considered significant using Student's t test versus GFP-MSCs. 
 
 
 
Oriented migration capacity of PG-MSCs and LMNA-MSCs in a modified Boyden's chamber assay 
under the effect of two inflammation-related chemotactic agents, SDF-1 and IL-8, is significantly 
increased when compared to the control GFP-MSC cell line (Fig. 4C). 
To examine the role of ROS in chondrogenic differentiation of the three MSC lines, we analyzed the 
effect of NAC on the process. Real-time RT-PCR revealed a statistically significant (P < 0.1) increase in 
the COL2/COL1 ratio of gene expression levels in cells treated with NAC in the GFP-MSC and LMNA-
MSC cell lines (Fig. 5A). The PG-MSC line was not affected by treatment with NAC, although COL2 
gene expression levels were significantly (P < 0.1) higher in NAC-treated compared to NAC-untreated 
PG-MSCs (data not shown). 
 
 
 
Figure 5. Effect of reactive oxygen species (ROS) on chondrogenic differentiation of mesenchymal stem cells (MSCs) transduced 
with green fluorescent protein (GFP), lamin A (LMNA) or progerin (PG). GFP-MSCs, LMNA-MSCs and PG-MSCs were incubated 
with 20 μg of N-acetyl-cysteine (NAC). Read procedure in Material and methods. Real-time reverse transcriptase polymerase chain 
reaction (RT-PCR) analysis for markers of chondrogenic differentiation and hypertrophy COL2/COL1 ratio (A), AGG (B) and 
MMP13 (C) are shown. *P < 0.1 was considered significant using Student's t test versus controls without NAC treatment. (D) 
Representative images of the tissue section from immunohistochemistry analysis with different antibodies against COL2, COL1, 
AGG and MMP-13. Magnification: 20 ×. 
  
In NAC-treated cultures, compared to untreated controls, AGG gene expression increased (Fig. 5B) 
and MMP-13 gene expression decreased (Fig. 5C) in LMNA-MSC and PG-MSC cell lines. In GFP-
MSCs there were no significant changes in AGG and MMP-13 gene expression. As well as the same 
results were found by immunohistochemistry analysis (Fig. 5D). 
Discussion 
We have demonstrated that deregulation of LMNA in our previously characterized chondrogenic model 
compromised chondrogenic differentiation through, partially, redox imbalance. Lamin A is a key factor 
regulating both normal and accelerated aging as well as stem cell differentiation. Aging is defined as the 
accumulation of diverse deleterious changes occurring in cells and tissues with advancing age that are 
responsible for the increased risk of disease and death (Harman, 2003). Aging is now considered to be a 
very complex, multi-factorial process. Several aging theories have been proposed (Tosato et al., 2007), 
but no single theory explains all the major age-related physiological changes. 
Premature aging syndromes are used as models to partially understand molecular causes of normal 
aging changes. Among those syndromes, Hutchinson–Gilford Progeria Syndrome (HGPS) is one of the 
most studied. Recent studies have proposed that stem cell dysfunction enhances both normal and 
premature aging symptoms (Scaffidi and Misteli, 2008 and Zhang et al., 2011). To examine that premise 
in our model of mesoderm line differentiation, and, specifically, chondrogenic differentiation through 
spheroid formation employing human UC MSCs, we used a lentiviral system to efficiently deliver genes 
of wt LMNA, PG and GFP, as a control. Gene expression levels were determined by immunoblot; 
LMNA-MSCs accumulated wt LMNA and PG-MSCs accumulated PG. The low level of PG detected 
may reflect the low passage number of the cell line, but is similar to the level found in an HGPS-derived 
fibroblast cell line, AG01972. Besides, nuclear defects and a decrease in the proliferation rate, both 
typical from PG-expressing, pre-senescent cells, are detected in PG-transduced MSCs. Mild nuclear 
defects and a decrease in proliferation rate are also detected in LMNA-transduced MSCs, indicating that 
nuclear accumulation of the wild-type isoform could alter the nuclear lamina similarly to PG 
accumulation, which agrees with previously published data (Young et al., 2006). By contrast, GFP-MSCs 
present similar proliferation rate than non-transduced MSCs. Therefore, we decided to use the GFP-MSCs 
as control for the differentiation experiments. 
We previously characterized MSCs from human umbilical cord stroma by flow cytometry 
(Supplementary Fig. 3) which showed a similar percentage of positive cells for surface markers CD105, 
CD90 and CD73 and negative for CD45 and 34 as found in former works by Arufe et al. (2011). We 
demonstrated that GFP-MSCs retain a differentiation potential similar to that of non-transduced MSCs. 
We then used the GFP-MSCs as a control for differentiation experiments for several reasons. Unlike non-
transduced MSCs, GFP-MSCs were transduced in parallel with the other cell lines that underwent 
lentiviral infection and puromycin selection. Also, GFP-MSCs over-express an exogenous protein. 
Extensive studies documented in the literature have verified that expression of GFP is innocuous for the 
cells. Finally, a recently published study demonstrated that lentiviral delivery of GFP into human UC 
MSCs did not affect their pluripotency (Qian et al., 2010). Alterations in the mesoderm differentiation 
potential were seen in the transduced cell lines, where osteogenesis, adipogenesis, and especially 
chondrogenesis were compromised in PG-MSCs compared to controls. In our model, we found calcium 
deposits secreted by PG-MSCs to be decreased after 21 days in osteogenic medium compared to GFP-
MSCs. One possible explanation for this might be the low level of expression of the ALP gene in these 
cells. In contrast, the significantly higher OC gene expression in LMNA-MSCs may indicate that 
osteogenesis is not altered in these cells. 
After 21 days in adipogenic medium, adipogenic capacity was lessened in PG-MSCs, demonstrated by 
a significantly lower expression of LPL and FABP genes than in control cells, as well as significantly 
lower (close to 50%) Oil Red staining. In contrast, LMNA-transduced cells show a significant increase in 
the expression of those adipogenic markers. Our results differ from those found previously by Kha et al. 
(2004). From their results, we would have expected to find an improved osteogenic potential in PG-MSCs 
because adipogenesis was reduced. One possible explanation for this unexpected result may be that all 
mechanisms of mesoderm differentiation in PG-MSCs were deregulated as a consequence of the over-
expression of PG in our model. 
Chondrogenic differentiation in our model is affected by deregulation of LMNA, especially in PG-
MSCs, as revealed by a lowered COL2/COL1 ratio and lower expression of COL2 and AGG as shown by 
real-time RT-PCR. While our findings do not completely agree with the results of the study by Scaffidi 
and Misteli (2008), any discrepancies may be explained by the different gene delivery methods, different 
origins of the MSCs, and the different differentiation models employed. 
The hypertrophy markers, MMP-13 and COLX, were detected significantly elevated in PG-MSCs by 
immunohistochemistry, compared to control, after 21 days in chondrogenic medium. Also, LMNA-MSCs 
presented an increase in COLX, but not in MMP-13. Real-time analysis showed that these two 
hypertrophy markers were significantly elevated in both PG and LMNA-MSCs. These results were 
similar to those found in OA chondrocytes (Blanco et al., 2011). Mitochondrial dysfunction and oxidative 
stress are known to be responsible for deregulation of chondrogenesis (Ruiz-Romero et al., 
2009 and Scott et al., 2010). We have previously reported that MnSODM is down-regulated in OA and 
that mitochondrial dysfunction and oxidative stress are responsible for deregulation of chondrogenesis 
(Blanco et al., 2011). Hence, we proposed to ascertain whether the diminished chondrogenic potential of 
LMNA-MSCs and PG-MSCs is linked to defects in MnSODM and oxidative stress imbalance. We 
investigated MnSODM levels at day 0. Western blot analysis demonstrated a decrease in total MnSODM 
in both cell lines, which was accompanied by a stable accumulation of ROS. This accumulation is 
partially, and dose-dependently, reversed by incubation of the cells with the antioxidant compound NAC, 
which acts as a ROS scavenger. Previously, a rapid and transitory increase in ROS generation in human 
MSCs from bone marrow has been proposed as the initial factor to sustain the migratory capacity of these 
cells (Busletta et al., 2011) suggesting a biphasic scenario for in vivo reparation of injured tissues. We 
decided to study if the migratory capacity in our in vitro model is altered in PG and LMNA-
overexpressing umbilical cord MSCs. Modified Boyden's chamber assay shows that these cells present an 
increased oriented migration capacity activated by two inflammatory chemokines, SDF-1 and IL-8, when 
compared to control GFP-MSCs. It is not unreasonable to think that the stable increase in ROS generation 
that we detected in our MSC model when the expression of lamin A is permanently altered, may interfere 
with the chain of events that leads to a proper migration of this cells. 
Gene expression levels of COL2 and COL1 were measured by real-time RT-PCR after 21 days in 
chondrogenic medium with and without NAC. The COL2/COL1 ratio indicates that NAC treatment 
improves chondrogenic differentiation. This ratio is significantly higher in GFP-MSCs and LMNA-
MSCs, comparing NAC-treated and -untreated cells, but not in PG-MSCs, although the COL2 gene 
expression level was higher in NAC-treated compared to NAC-untreated PG-MSCs (data not shown). 
The hypertrophy phenotype is lessened by NAC treatment in LMNA- and PG-transduced cells, as shown 
by increased AGG and decreased MMP-13 gene expression levels. These results indicate that LMNA-
MSCs and PG-MSCs were more sensitive to NAC treatment because of an accumulation of ROS that 
correlates with a decrease in MnSODM protein levels. Our results are in agreement with those of Morita 
et al. indicating that ROS levels regulate the inhibition of proliferation and modulate the initiation of 
hypertrophic changes in chondrocytes (Morita et al., 2007) and with recent work demonstrating the 
importance of ROS levels during stem cell differentiation (Hao et al., 2011) (Aly et al., 2011). 
Conclusion 
Overall, our results show that chondrogenic differentiation of UC-MSCs is compromised by lamin A 
deregulation. We also demonstrated that this deregulation alters the oxidative stress balance in MSCs, 
modifies their migratory properties and induces defects in their capacity to differentiate into chondrocytes 
in our in vitro model. Further experiments are necessary to determine the in vivo significance of these 
alterations and to explore putative key targets for stem cell therapies in OA and other aging syndromes. 
The following are the supplementary data related to this article. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 1. Characterization of mesenchymal stem cells (MSCs) transduced with green fluorescent protein (GFP). Real-
time reverse transcriptase polymerase chain reaction (RT-PCR) data for the expression of differentiation markers (A). GFP and 4′,6-
diamidino-2-phenylindole (DAPI) signals of a GFP-MSC spheroid (B) and a non-transduced MSC spheroid (C). Histological 
analysis of 21-day spheroids from GFP-MSCs (D, G and J) and non-transduced MSCs (E, H and K). Oil-Red staining (D and E); 
calcium deposit staining with alizarin red (G and H); and collagen type 2 (COL2) immunostaining (J and K); real-time RT-PCR 
analysis of differentiation genes for adipogenesis (F), osteogenesis (I) and chondrogenesis (M).*P < 0.05 is considered significant 
using Student's t test versus GFP-MSCs. CH = chondrocyte control. Magnification: 20 ×. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 2. Characterization of mesenchymal stem cells (MSCs) transduced with green fluorescent protein (GFP), 
lamin A (LMNA) or progerin (PG). Representative images of the tissue section stainings corresponding to the osteogenic (alizarin 
red), adipogenic (Oil Red O) and chondrogenic (COL2, COL1, safranin O, COLX and MMP13) differentiations of each transduced 
lineage. 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 3. Characterization of mesenchymal stem cell population from human umbilical cord stroma. Flow cytometry 
of the surface markers; CD34, CD45, CD73, CD90 and CD105. In each diagram, at the top is the name of the marker, at the bottom 
the fluorochrome used and at the top right the percentages of positive cells. Isoty = Isotype. 
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